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The Total Food Effect: Exploring Placebo Analogies in 
Diet and Food Culture
Cory S. Harris, PhD*,†; Timothy Johns, PhD†
Food and medicine share an inseparable history with essential evolutionary underpinnings.  In ad-
dition to nutritional, medicinal or toxic components, the tastes, colours, shapes, names and labels 
of foods elicit emotions, expectations, associations and conditioned responses rooted within both 
public consciousness and individual experience.  This combination of chemical-driven bottom-up 
and meaning-driven top-down influences provides a fertile framework through which to explore 
metaphors of placebos and placebo-like effects.  As reviewed, elements of placebo are widespread 
in food culture, appearing in numerous forms and with varying degrees of resemblance to those 
observed in medicine.  We first adapt a model of placebo from the medical literature for applica-
tion to the subject of food, diet and nutrition. Exploring the intricate interactions between drug 
or food, patient or consumer, and doctor or food source within different settings and contexts, we 
then demonstrate that the total effect of any food, meal or diet is seldom, if ever, strictly a function 
of nutritional composition or chemically-driven bottom-up effects.  In closing, we summarize and 
integrate our observations relative to current understandings of placebo effects in medicine. 
Introduction
Central to human health and survival, food and 
medicine share an inseparable history with es-
sential evolutionary foundations (Johns, 1999). 
In Chinese, Ayurvedic and Hippocratic-derived 
traditions, many indigenous healing practices 
and modern biomedicine alike, diet and nutri-
tion are vital components of health maintenance 
and recovery from disease.  Like medicines, foods 
contain biologically-active chemicals but also 
carry social and cultural meanings that contrib-
ute to their impact on our personal and collec-
tive health (Etkin, 1986).  A distinction between 
food and medicine that emerged in the 19th and 
20th centuries sets Western industrialized so-
cieties apart from most of world`s indigenous 
cultures of the past and present (Etkin & Johns 
1998).  Even in Westernized cultures, items such 
as vitamins, coffee, wine and `magic` mushrooms 
straddle the line while healthy eating movements 
and the health food industry are trying to erase it 
altogether.
In this light, the concept of placebo, generally 
defined in medical terms, may extend to our ex-
periences of food and diet.  Although the idea of a 
placebo hamburger may at first seem far-fetched 
(or like a dieter`s dream), a more nuanced ap-
proach reveals that food-related placebos and 
placebo effects abound — even if they, like their 
medical counterparts, appear in different forms 
and contexts.
A brief survey of food-related 
placebos and placebo effects 
In clinical research, whether pharmacological or 
nutritional, placebos serve to control for the ef-
fects of time and participation in a study. While 
treatment with ‘pure’ placebos is likely less com-
mon in clinical nutrition than reports suggest of 
medical practice (Fässler, Meissner, Schneider, 
& Linde, 2010), nutritional interventions lacking 
evidence of efficacy from randomized controlled 
trials (RCTs) are widespread and may, in effect, 
constitute ‘active’ placebos.  This is the case for 
many Complementary and Alternative Medicine 
(CAM) practices, collectively equated to ‘mere’ 
placebos following systematic reviews of RCT data 
‡ (Bausell, 2007; Singh & Ernst, 2008). Similarly, 
some physicians prescribe vitamins in situations 
without demonstrated or expected clinical effica-
cy (Raz, et al., 2011; Tilburt, Emanuel, Kaptchuk, 
Curlin, & Miller, 2008).  
A reliable paradigm for placebo research 
(Fillmore, Mulvihill, & Vogel-Sprott, 1994; 
Hammami, Al-Gaai, Alvi, & Hammami, 2010; 
Testa et al., 2006), drug-like foods such as caffein-
ated or alcoholic drinks and their inactive placebo 
counterparts offer everyday opportunities to expe-
rience placebo effects.  For other examples, how-
ever, the analogy is more subtle.  While food al-
lergies and intolerances are immunologically and 
metabolically founded, personal experience, con-
ditioning and expectancies undoubtedly influence 
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individual responses as well.  Relatedly, food aver-
sions and taboos, which can also provoke physi-
ological responses when challenged, are founded 
in personal and cultural beliefs, sometimes with 
little or no basis in biology.  Like taboo foods, 
comfort and ceremonial foods are defined by spe-
cific cultural and religious contexts.  Although 
their chemical composition is often nutritionally 
or pharmacologically unfavourable, these foods 
offer a sense of comfort, contentment, tradition 
and connectedness that nonetheless contribute to 
mental health and well-being.  In many cultures, 
foods may also be magical, sacred or curative, 
elevating their spiritual status and psychological 
impacts (Simoons, 1998) 
In Westernized cultures of dieting and health 
foods, analogies of placebo are hard to avoid. 
From fad diets to hypnotic suggestions, count-
less people turn to alternative strategies for los-
ing weight — at times with remarkable success. 
Conversely, product labels advertising “reduced 
fat”, “low sodium”, “organic” or “natural” often 
mislead consumers into false perceptions of a 
food’s nutritional value, safety or environmental 
footprint.  The expanding and largely unregulat-
ed health food* industry markets their products 
with reference to disease prevention and healthy 
aging, claims often based in scientific evidence 
but rarely supported by RCTs as required for 
pharmaceuticals.  Emerging commercial inter-
est in the marketing of functional foods with 
approved, evidence-based health claims draws 
attention back to placebos as controls in clinical 
research.
As illustrated by the examples listed above, 
whether closely or loosely related to medical pla-
cebos, foods are much more than the sum of their 
chemicals.  As symbols, they create meaning that 
our minds and bodies interpret on a physiologi-
cal level, influencing our food choices and health 
for better or for worse.  Capturing the multi-
dimensional nature of our relationships and in-
teractions with food is not easily accomplished 
through a single lens but instead requires an in-
terdisciplinary approach.  But where to start?
Adopting a model
Social scientists contribute important placebo-
related insights on dietary habits, food choice 
and nutrition (Booth, 1994; Drewnowski & Rolls, 
2005; Wansink, 2004).  Although direct reference 
to placebo is rare, elements and terminology such 
as belief, expectancy, conditioning and context 
are clearly compatible with medical perspectives. 
As examined in this two-part special issue, sever-
al conceptualizations of placebo remain relevant 
outside of medicine (Kirmayer, 2011; Moerman, 
2011; Orsini & Saurette, 2011).  The concepts of 
‘context effects’ (Di Blasi & Kleijnen, 2003) and 
‘belief effects’ (Evans, 2003) also offer insight 
transferrable to food culture while, serving as 
a proxy for psychological and cognitive factors 
contributing to treatment responses in medicine, 
Moerman’s meaning response is especially ger-
mane (Moerman, 2002).  
As a promising model for exploring placebos 
in food culture, the “Total Drug Effect” (TDE) 
forwarded by Claridge (1970) and developed by 
Helman (2001, 2007) stands out in accommodat-
ing interacting contributions of multi-dimen-
sional factors as well as variability in individual 
responses.  According to Claridge (1970), the 
overall effect of a drug depends not only on its 
pharmacological properties but on the collective 
and interacting attributes of the drug, the patient, 
the physician and the physical setting.  By add-
ing the overarching social, cultural, economic 
 
* Foods marketed with 
claims of improving 
or maintaining health.  
Regulated like other foods 
in the U.S., health foods are 
regulated separately and 
more strictly in Canada and 
many EU nations.
A
B
Figure 1. (A) The Total Drug Effect model adapted from Helman (2007) and (B) the Total 
Food Effect model.  By removing the pharmacological (P), toxicological (T) and/or nutritional 
(N) components of a drug or food from the model, remaining effects on the patient or consum-
er can be interpreted as placebo-like and explained through interactions between the remain-
ing elements. The dashed line indicates that the micro-context is distinct from, yet embedded 
within, the macro-context.  The dotted line around the source signifies its potential ambiguity 
in, or absence from, the total food effect.
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and political environment (macro-context) to the 
physical setting (micro-context) in which drug 
use takes place, Helman extends the model to 
all forms of drug use, from pharmaceutical and 
CAM to recreational and social (Helman, 2001, 
2007).  We discuss each component of the TDE 
(Figure 1A) in further detail in the next section 
but let us first briefly consider who consumes 
what, when, where and why. 
For the sake of simplicity, we assume that ev-
eryone consumes food and medicine.  In terms 
of what is consumed, the list is virtually endless. 
What constitutes a food or a medicine — and what 
an individual or society accepts as such — is large-
ly culturally and socially defined though rooted 
in biological factors such as toxicity, digestibility 
and palatability (Moerman, 1996). Although peo-
ple can consume food or medicine whenever and 
wherever desired, the time and place for eating 
and medicating are, again, generally prescribed 
by social and cultural norms.  Unlike medicines, 
however, foods are consumed daily unless un-
available or avoided, from birth until death.  
Both food and medicine maintain health and 
ultimately survival but the reasons people eat 
differ from those for medicating — at least at the 
surface.  While a complete review of the physi-
ological and psychological mechanisms underly-
ing food choice and dietary habits is beyond the 
scope of this paper, the influences of homeostasis 
and reward contribute powerfully and insepa-
rably (Lutter & Nestler, 2009; Volkow, Wang, & 
Baler, 2011; Zheng, Lenard, Shin, & Berthoud, 
2009).  People seek medication, food or water to 
relieve discomfort associated with disease, hun-
ger or thirst.  One noteworthy difference is that, 
whereas most healthy people have little desire to 
medicate, satiated people often remain motivated 
to eat.  We not only eat to relieve hunger and ob-
tain nutrients but for the sensory satisfaction, the 
provided comfort and the variety of social and 
cultural functions food serves.  People also eat 
out of habit regardless of hunger, appetite or need. 
Adapting the model 
Despite the similarities and associations, the dif-
ferences between food and medicine require that 
we redefine certain elements of the TDE model. 
The proposed Total Food Effect (TFE) neverthe-
less remains comparable in both structure and 
concept (Figure 1B).  To bridge between models, 
we often refer to CAM, particularly natural health 
products as they fall somewhere in the middle 
of the food–medicine spectrum in terms of both 
chemistry and regulation.
Drug to Food
Medical treatments are more than their active or 
specific components.  Treatment can be delivered 
in many forms (pill, injection, inhalation device, 
surgical or physical manipulation) that may have 
distinct colour, shape, size, taste, odour, physical 
sensation, name and marketing platform.  The 
same is true for foods.  Consider the endless va-
riety of candy, each with its own colour, shape 
and brand name but all primarily from a single 
ingredient — sugar.  Beyond diversity in form, the 
immediate sensory stimuli associated with eat-
ing, including aesthetic appeal, taste, aroma, tex-
ture and consistency, provide additional inputs to 
which the body and mind respond.  This sensory 
richness is influenced by both culture and biology 
but founded primarily in chemical diversity.  
Foods are far more chemically complex than 
pharmaceutical drugs.  Most foods contain a 
chemical diversity unmatched by even the most 
complex drug regimen.  An apple, for example, 
contains hundreds if not thousands of different 
molecules belonging to dozens of distinct chemi-
cal classes.  Given frequent potential for drug–
drug interactions when medications are com-
bined, direct and indirect interactions among 
apple constituents are inevitable. The assortment 
of ingredients to make a dish, of dishes to make 
a meal and of meals to make a diet renders this 
complexity, together with related biochemical 
interactions, hard to imagine let alone assess 
experimentally.  Moreover, whereas the specific, 
chemical-based effects of drugs are rooted in 
pharmacology and toxicology, such contribu-
tions are considered secondary to nutrient con-
tent when considering foods.  
When lacking, in excess, or simply con-
sumed, nutrients elicit specific responses that in-
fluence mood, behaviour and health.  As such, we 
have added a nutritional component to the TFE 
(Figure 1B, “N”).  Pharmacological effects are 
generally less pronounced with foods, in part be-
cause drugs are optimized for potency and in part 
because highly bioactive natural substances in 
foods often taste bitter or unpleasant (much like 
medicines) and may be eliminated or reduced 
through breeding, processing or cooking.  A final 
distinction of note relates to consistency between 
products.  Among other factors, food chemistry 
depends on genotype, growth and harvesting 
conditions, transport and storage, processing and 
cooking methods, etc.  Two apples on the same 
tree are unlikely to have the same chemistry, 
much less two apples of different varieties grown 
in different climates.  Conversely, pharmaceuti-
cal drugs are produced following strict protocols 
Natural health 
products  
Naturally occurring sub-
stances including vitamins, 
amino acids or essential 
fatty acids, probiotics and 
herbal remedies that are 
safe, used to restore or 
maintain health and avail-
able without a prescription. 
(http://www.hc-sc.gc.ca/
dhp-mps/prodnatur/about-
apropos/cons-eng.php)
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to ensure that each dose of a given treatment is 
chemically and visually identical.  However, like 
medicines, even if all apples were identical, the 
total effect on health would nonetheless depend 
on the person eating.
Patient to Consumer
Most attributes of a treatment or food can be mea-
sured or at least observed directly. Even cultural-
ly-derived attributes like name and price usually 
relate to physical and chemical properties.  The at-
tributes of people are far more varied; in addition 
to physical and socioeconomic traits, people have 
personalities, experiences, beliefs, expectations 
and unconscious responses that, together with 
their individual chemistry and biology, change 
with time.  As such, the transition from patient 
to consumer is fairly straightforward.  Attributes 
relating to genetics and pre-existing health are 
similarly applicable to both models for obvious 
reasons.  The role of others, such as personality 
and expectancies, may be more subtle or variable; 
shyness, tenacity and suggestibility will manifest 
themselves differently at the dinner table com-
pared to the doctor’s office.  For instance, we 
expect foods to provide flavour, relieve hunger, 
perhaps lead to intoxication, indigestion, aller-
gic reactions or weight change but, in general, to 
have no great influence on immediate health and 
physiology. In this regard, we expect far more of 
medicines — observable improvements in health 
or, alternatively, adverse effects. 
Prescriber to Source
In Claridge’s TDE model (1970), the prescriber, 
generally a medical practitioner, plays an integral 
role.  Maintaining its central position in Helman’s 
modified model, the prescriber can be a practitio-
ner but also a drug dealer or peer providing ac-
cess to or information about drug-like substances 
(Helman, 2001, 2007).  In all cases, the compo-
nent linking treatment to patient is a living per-
son.  Consequently, the attributes are human, as 
for patients and consumers.  Affecting both genu-
ine and perceived competence and therefore the 
TDE (Benedetti, 2010; Moerman, 2002), profes-
sional credentials, reputation, bed-side manner 
and personal appearance are particularly impor-
tant. But what if no practitioner or prescriber is 
involved, for example taking ibuprofen to relieve 
pain based on common knowledge?  
For CAM practices, the definition and role of 
prescriber is evident when seeing a homeopath, 
healer or other practitioner but begins to blur 
when self-prescribing herbal remedies or prac-
ticing meditation and yoga.  The prescriber may 
resemble the peer in Helman’s model — some-
one or something (like a commercial or website) 
endorsing or providing access to a given treat-
ment — but may also be interpreted as any step in 
the physical or philosophical supply chain link-
ing product or practice to consumer: from source 
of material (e.g. a plant) to producer, distributor 
and vendor or from source of knowledge (e.g. 
Hinduism) to philosopher, teacher and text.  As a 
result, the notion of prescriber is better represent-
ed by the term source, which we have adopted for 
the TFE model. 
Depending on the consumer and context, the 
source of a food, meal or diet could encompass 
the entire food production chain, from farm to 
table, or simply the final stages to which most 
industrialized consumers are predominantly ex-
posed.  If the latter scenario prevails, the role of 
individual people, from caregivers and grocers to 
restaurant staff and celebrity chefs, is once again 
apparent and salient.  Alternatively, if any or all 
steps in the food supply chain are regarded as the 
source, the role of specific individuals diminish 
compared to that assigned to overarching corpo-
rations, technologies, policies or ideologies.  For 
people of farming and hunter–gatherer commu-
nities, the source may be viewed as soil, sun and 
water, the fruit of one’s labour or spiritual forces.
Information about food and diet in the form 
of recommendations, health claims, recipes, etc., 
provided personally or through popular culture 
and mass-media, can direct choice and impact 
health outcomes.  Attempting to assign such at-
tributes to the source inevitably merges with 
those of the food, the consumer, and the micro- 
or macro-context.  As such, the source compo-
nent of the model is illustrated with a dashed line 
(Figure 1B) to indicate its variable and potentially 
ambiguous contribution to the TFE.
Micro-context
Characterized by the physical and social setting 
in which eating or treating take place, the micro-
context of most medical treatments involves a 
consultation in a healthcare-oriented environ-
ment with subsequent administration or use 
of the prescribed intervention on site, at home 
or wherever else symptomology and compli-
ance dictate.  With fewer constraints, people eat 
virtually anywhere and anytime desired.  Little 
distinction is nonetheless required between the 
micro-context of the TDE and that of the TFE. 
Clearly, the type of establishment (or lack thereof, 
e.g. battlefield bunker, highway) and its related 
characteristics are central.  Beyond structural 
and sensory elements, micro-context is further 
defined by geographical location, time of day, 
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time of year, and weather as well as the presence 
and interactions of other people, participating or 
not, and the social group(s) to which they belong. 
Together, these combined factors not only create a 
dynamic micro-context that is seldom replicated 
but contribute to psychological and physiologi-
cal responses to medicine, food and placebos. 
Increasing evidence suggests that the structural 
and aesthetic design of healthcare facilities can 
impact health outcomes (Rubin, 1998) by influ-
encing stress levels and rates of disease transmis-
sion among both patients and healthcare workers 
(Ulrich, 1992, 1997).  How setting may affect food 
choice, eating behaviours and related responses to 
food, a topic we revisit in the following section, is 
similarly receiving increased attention.
Macro-context
The prevailing societal attitudes and values, the 
socio-economic and political climate, as well as 
the region’s history, customs, geography and bio-
logical diversity are equally pertinent to the con-
sumption of both medicine and food.  Aborting 
a pregnancy and eating pork respectively present 
specific medical and nutritional consequences 
of the macro-context.  Doing the former within 
a Catholic society or the latter within an Islamic 
one, however, may result in additional effects 
on social, psychological and physical health, re-
gardless of personal attitudes and motivation. 
Language is a particularly important compo-
nent of macro-context.  Classification systems 
organize everyday life, including medicines and 
foods, into meaningful categories based in cultur-
al beliefs and shaped by language (Bowker & Star, 
1999; Foucault, 2002).  Moreover, multiple inde-
pendent classification systems may co-exist, each 
contributing different labels and meanings to the 
same thing.  Eggs are not just part of the ‘meat 
and alternatives’ food group; they may be a break-
fast food, an animal-based food, a taboo food, a 
nutrient-rich or high-cholesterol food, a yin (or 
cooling) food in Traditional Chinese medicine or 
a pungent, heating food in Ayurveda.  Although 
classification systems are embedded within the 
macro-context, the pertinence of assigned labels 
varies from person to person and from place to 
place.  Other factors, such as popular knowledge 
and stereotypes surrounding specific treatments, 
foods and the people associated with them, con-
tribute to macro-context as well.  When consid-
ering historic scenarios, the era is an essential 
consideration.  For example, a barber’s pole, once 
symbolic of the profession’s dual role as surgeon, 
conveys a very different meaning today.
Placebo drugs to placebo foods
An obvious limitation of the proposed model 
is the lack of nutritionally inert foods — or pure 
placebos — in food and diet.  That food-related 
placebos are almost always active placebos has 
practical and conceptual consequences for the 
TFE and placebo research in diet and nutrition. 
Placebo pharmaceuticals are straightforward; an 
inert substance is substituted for the pharmaco-
logically active ingredients without significant 
impact on appearance or taste.  Because pills are 
manufactured, the active can simply be omitted 
in place of the selected filler.  Moreover, because 
pills are typically small and swallowed whole, 
the potential sensory and physiological effects 
of the filler are minimized.  In contrast, placebo 
foods may designate either pharmacological (e.g. 
caffeine-free) or nutritional (e.g. fat-free) inertia. 
Whereas placebo versions of manufactured food 
can be easy to make, for instance not fortifying 
otherwise fortified foods, making placebos from 
whole foods is much more difficult.  
In some cases, such as caffeine- and alcohol-
free beverages, the extraction of drug-like non-
nutrients is accomplished without greatly altering 
chemistry and sensory quality. The extraction of 
nutrients, conversely, is severely complicated by 
several factors.  Most notably, nutrients make 
up the bulk of food; once removed, little is left 
save water (which many consider a nutrient). 
Exemplified by low-fat dairy products, specifi-
cally removing one type of macronutrient is more 
feasible but, interacting directly with sensory and 
homeostatic systems, its absence is easily recog-
nized.  For research purposes, particularly food 
challenges for allergy assessment, placebos are 
most often developed to mask the taste of both 
the “active” and placebo foods, which is simpler 
than simulating original sensory stimuli but lim-
its the relevance to dietary preference and habit 
(Huijbers et al., 1994; Noe, Bartemucci, Mariani, 
& Cantari, 1998). 
What is an appropriate filler for placebo 
foods?  Lactose, a traditional pharmaceutical 
placebo, is neither nutritionally nor physiologi-
cally inert.  Substituting any food component 
with lactose is thus the nutritional equivalent of 
substituting one active drug with another.  Since 
foods are consumed in much larger quantity than 
drugs, finding fillers that mimic food qualities 
without altering digestive and metabolic pro-
cesses is nearly impossible.  Adding something 
indigestible, like most fat substitutes, likely affects 
sensory appeal but also interferes with nutrient 
digestion and absorption in the gastrointestinal 
Active placebos 
Interventions containing 
active chemicals or compo-
nents with no direct effect 
on the targeted problem, 
such as antibiotics for viral 
infections and vitamins for 
headaches.
Pure placebos 
Interventions containing no 
active chemicals or compo-
nents, such as sugar pills and 
saline injections.
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system.  Similarly, many sugar replacements are 
neither calorie-free nor biologically inactive.  The 
lack of pure placebo foods confounds the study 
of non-nutrient effects since observed differences 
between placebo and experimental groups are 
not strictly attributable to top-down influences. 
On the other hand, so long as these limitations 
are acknowledged and controlled for, placebo 
foods — like placebo drugs — offer both a use-
ful investigative tool and a potentially powerful 
health intervention. 
Integrating the total food 
effect
How do interactions of the model’s components 
influence individual food-related perceptions, 
behaviours and responses?  Because the role of 
the practitioner translates inconsistently into the 
TFE model, we only briefly explore the source–
consumer and source–food relationships before 
focusing on consumer–food interactions and the 
impact of micro- and macro-context.
The prescriber–patient and 
source–consumer relationships
When an identifiable person prescribes, suggests 
or prepares food (or a dietary plan) for the pur-
pose of improving the consumer’s health, interac-
tions between the source and consumer influence 
the TFE as in medicine.  The words, attitudes, reli-
ability and behaviours of a practitioner can elicit 
neurological and physiological responses that im-
pact patient trust and hope, perceptions of em-
pathy, competence and — most importantly — re-
covery (Benedetti, 2010; Prévost, Zuckerman & 
Gold, 2011).  For example, in a study on the effects 
of language in general practice consultations, 64% 
of patients recovered shortly after a ‘positive’ con-
sultation consisting of a firm diagnosis and as-
surance of rapid recovery compared to only 39% 
among those receiving no diagnosis and uncer-
tain prediction of recovery, regardless of symp-
toms, placebo prescription or sex (Thomas, 1987). 
Indeed, language is a fundamental vehicle of 
suggestion (Shapiro, 2004), which in turn trig-
gers both conscious and unconscious cognition 
leading to altered perception and behaviour (Raz, 
Moreno-Iniguez, Martin, & Zhu, 2007).  Less 
subtle than suggestion, explicit information, for 
instance telling the patient what intervention they 
will receive and when it will be administered, elic-
its similarly mediated responses.  Demonstrated 
repeatedly using open/hidden research para-
digms, patients made aware of drug administra-
tion consistently respond better than uninformed 
patients, whether for treatment of pain, anxiety 
or Parkinson’s disease (Colloca, Lopiano, Lanotte, 
& Benedetti, 2004).  Without the involvement of 
placebos, these interactions can be more aptly at-
tributed to “knowledge” or “attentional” effects.  
Relationships with dietitians and personal 
trainers represent obvious examples of source–
consumer interactions but reported health ben-
efits of home-cooked meals suggest that similar 
interactions exist with parents and care-givers. 
Eating at home or as a family, independent of 
factors like household income and education, is 
frequently identified as a positive contributor to 
diet quality, nutrient intake, and health, especially 
in children and adolescents (Briefel & Johnson, 
2004; Patrick & Nicklas, 2005; Scaglioni, Salvioni, 
& Galimberti, 2008).  Foods purchased and 
prepared by care-givers at home are not just 
nutritionally sound and dependable but im-
bued with the comfort and protection of family. 
Alternatively, unhealthy eating environments in 
the home can promote problematic eating behav-
iours in children (Scaglioni, et al., 2008).  
If identified as commercial, the source’s at-
tributes and actions may impact consumer ex-
pectancies, choices and experiences but few have 
explored how such interactions influence health. 
One pertinent example is transparency on the 
part of food retailers regarding the nutritional 
value of their products, a legislated requirement 
in an increasing number of countries.  Nutritional 
information may be listed on packaging, posters, 
pamphlets or menus but is often relegated to a 
company webpage.  Whereas such information is 
infrequently accessed and unlikely retained un-
less available at the point of purchase (Bassett et 
al., 2008; Roberto, Schwartz, & Brownell, 2009), 
menus offer more promise in terms of calorie con-
trol.  In a recent study (Roberto, Larsen, Agnew, 
Baik, & Brownell, 2010), diners presented with 
calorie-labelled menus ordered and consumed 
fewer calories than diners unaware of their ca-
loric intake but increased their consumption to 
comparable levels when menus were redistribut-
ed after the meal.  Only the diners presented with 
both calorie content and recommended daily 
intake consumed fewer calories throughout the 
study suggesting that listing calories on menus 
influences food choices and that nutritional rec-
ommendations alongside calorie labels more ef-
fectively controls consumption.  Such knowledge-
based or attentional effects may also involve other 
cognitive processes since the experimental milieu 
also allows for Hawthorne effects and mediation 
by social norms, pressures and appearances when 
eating in public.
Hawthorne effects  
The modification of normal 
behaviour resulting from 
being monitored or par-
ticipating in a study (rather 
than from experimental or 
environmental manipula-
tions). 
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The prescriber–drug and source–
food relationships
Food selection based on knowledge or expecta-
tions of benefit is generally in the hands of con-
sumers whereas, as illustrated by the preference 
for double-blinded clinical evidence in medi-
cine, a prescriber’s knowledge and expectation of 
therapy can modulate patient outcomes for better 
or worse (Gracely, Dubner, Deeter, & Wolskee, 
1985).  The relationship between practitioner and 
treatment is based on knowledge gained through 
prior experience as well as information gleaned 
from education and training, colleagues, sales 
representatives, seminars and the media.  This 
relationship not only influences interactions with 
patients but guides practitioners in selecting from 
the ‘menu’ of appropriate treatment options once 
a diagnosis is reached. Comparable situations 
arise when consumer food choice is limited.  For 
example, based on their expertise and knowledge, 
a chef will choose and prepare only the best avail-
able foods to serve customers.  Similarly, a mother 
will choose and prepare only the best to serve her 
family — particularly if someone is unwell.  When 
her son has the flu, a mother may serve him soup 
or some other comfort food that she knows pro-
vides energy and hydration but that she also ex-
pects will help him feel better based on her ex-
perience with other children and, perhaps most 
importantly, as a child herself.  
When the source is a caregiver or anyone with 
a vested interest in providing the consumer with 
safe and nutritious meals, the impact of their re-
lationship to foods on the TFE is often positive 
in terms of health and nutrition.  This, however, 
is not always the case.  Competing factors such 
as profit margins and consumer preference in 
the private sector (Glanz et al., 2007) or resource 
availability and food allergies in the public sector 
(Gregoire, 1994) must also be considered. 
If the source stands to gain financially from 
the provision of food, the role of motivation re-
quires some attention.  Though a cynic may sug-
gest otherwise, a physician’s primary concern is 
patient health regardless of personal advantage. 
For practitioners whose income depends on non-
pharmaceutical therapies in which they believe, 
the net impact of the prescriber–treatment rela-
tionship likely remains positive, particularly since 
patient improvement leads to repeat business and 
referrals.  In contrast, for food producers and re-
tailers, customer satisfaction and sales do not nec-
essarily equate with positive nutritional value or 
health outcomes.  Such considerations are usually 
secondary to palatability, convenience and econ-
omy, which collectively contribute to the flood of 
high-calorie, low-cost processed foods and the 
rising rates of obesity in America (Drewnowski 
& Darmon, 2005).  
Source actions affect the attributes of food. 
Strategically designed by industry to meet strict 
regulatory guidelines and marketing goals, food 
labels selectively draw attention toward de-
sired attributes and away from undesired ones. 
Though nutritional information is often includ-
ed, many consumers ignore or don’t understand 
it (Cowburn & Stockley, 2005).  By manipulating 
the attributes of the food (label, price, colour), the 
source influences consumer beliefs and expecta-
tions.  Sources directly impact food chemistry 
as well.  Because doctors no longer prepare the 
drugs they prescribe, their only influence on drug 
chemistry is dosing.  Cooks don’t just select their 
ingredients but measure, mix and prepare them 
as they choose.  Affecting the already diverse and 
variable chemistry of foods, a source’s chosen 
practices of farming, processing, storage and/or 
cooking influence both nutrient content and food 
safety (Bhat, 2008).
The patient–drug and consumer–
food relationships
Pharmacology and nutrition
Central to patient–drug interactions, the bio-
chemical and subsequent physiological activi-
ties of pharmacotherapy provide the transition 
to consumer–food interactions.  Whether con-
suming food or medicine, individual responses 
are rooted in biology.  A drug, once delivered, 
must reach its specific target within the body 
in its active form at sufficient concentrations. 
This depends on — among other things — drug 
transport, metabolism and clearance processes 
that are largely predetermined by genetics. Age, 
weight, overall health and external factors (in-
cluding diet) also alter pharmacokinetics and 
pharmacodynamics.  Moreover, the presence of 
other drugs, foods or toxins metabolized in the 
liver can disrupt enzyme function to the same ef-
fect.  Garlic and grapefruit, for instance, contain 
substances that increase drug levels by inhibit-
ing metabolic enzymes and transport pumps 
(Diaconu, Cuciureanu, Vlase, & Cuciureanu, 
2011; Gallicano, Foster, & Choudhri, 2003). 
Outside of pharmacology, active drugs and their 
metabolites can elicit allergic responses or gastro-
intestinal disturbances with considerable impact 
on the TDE.  
The interactions between constituents of 
foods or natural health products generally follow 
the same principles and are subject to the same bi-
ological and environmental factors.  As examples, 
genetics and epigenetics underlie the reduced 
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capacity to metabolize alcohol and lactose in 
people of certain ethnic backgrounds (Edenberg, 
2007; Swallow, 2003), a full stomach slows the ab-
sorption of alcohol along with the ensuing onset 
of cognitive impairment (Millar, Hammersley, & 
Finnigan, 1992) and vitamin C improves the up-
take of iron from non-animal sources (Hallberg, 
Brune, & Rossander, 1986).  Immune system-
mediated allergies are likewise embedded in con-
sumer biology.  On the other hand, unlike drugs, 
nutrients are essential to everyday body and brain 
function so many are specifically monitored and 
regulated by the central nervous, endocrine and/
or immune systems. Deficiency or excess of any 
nutrient is, in itself, a health concern only rem-
edied by increasing or decreasing the availability 
of the particular nutrient.  Offering a simple if not 
pure translation of Claridge’s TDE into clinical 
nutrition, these situations warrant a closer look. 
Tightly and efficiently regulated, macronu-
trients are stored or excreted when consumed 
in excess but long-term consequences include 
weight gain, metabolic diseases, kidney problems 
and cardiovascular disease (Hung, Sievenpiper, 
Marchie, Kendall, & Jenkins, 2003; Pecoits-Filho, 
2007).  Genetics play a role in the metabolism 
and storage of macronutrients, which together 
with age, physical activity and lifestyle not only 
influence our capacity to process and respond to 
foods but contribute to diet-related disease and 
death.  In contrast, excesses of vitamins and min-
erals can lead to immediate and severe toxicity 
requiring immediate medical attention.  Beyond 
overloading on iron, which has an established 
genetic component (Brissot et al., 2005), biologi-
cal traits are largely irrelevant compared to diet, 
supplementation and exposure to environmental 
contaminants.  In terms of nutrient deficiencies, 
the relevant consumer traits outside of diet are 
again seldom biological. Instead, economic, so-
cial, political, geographical and ideological fac-
tors, which are equally pertinent to situations of 
over-nutrition, are the primary contributors to 
nutrient deficiency (Tanumihardjo et al., 2007).  
In all of these examples, nutrient content 
would dominate consumer–food interactions 
and the TFE, at least in terms of health effects; re-
moving the nutrient component from the model 
renders the long-term prognosis for nutrient 
deficient individuals as poor regardless of any 
positive psychosocial benefits the food may of-
fer.  When energy-deprived, even if conditioned 
responses to the sight, smell and act of eating 
briefly reduce perceived hunger, such short-lived 
relief is of little benefit.  The opposite argument 
generally holds for nutrient poisoning and over-
nutrition — consumers would benefit from the re-
moval of the nutrient in excess — except that, for 
the latter, the lack of energy dense carbohydrates 
and fats can also alter taste or texture and forego 
the addictively rewarding stimuli that contribute 
to chronic overeating (Smeets, Weijzen, de Graaf, 
& Viergever, 2011; Stubbs, 2001).  Accordingly, 
any ensuing reduction in food intake is soon fol-
lowed by renewed urges.  
Flavour
Beyond nutrition and pharmacology, foods pro-
vide taste, odour, texture and colour as gusta-
tory, olfactory, somatosensory, auditory, visual 
and trigeminal inputs that together determine 
individual flavour perception.  Given the neces-
sity of obtaining nutrients and avoiding poisons, 
our senses and responses evolved for these very 
purposes; we innately prefer sweet and salty, an 
indication of nutrient-rich foods, over sour and 
bitter (Birch, 1999).  Several genes involved in 
taste perception have been identified, particularly 
with regard to bitter, sweet and umami sensitiv-
ity.  Smoking and toxic exposure can also impact 
perception of chemical stimuli, as can personal 
health, particularly with regards to the respirato-
ry and olfactory systems.  Once perceived, subse-
quent responses and behaviours depend not only 
on the individual’s sensitivity but on their prior 
experience with the specific food and its qualities 
as well as their personal dietary habits, prefer-
ences and traditions (Lindemann, 2001; Logue, 
2004).  Flavour perception is a fertile field of re-
search with wide ranging implications for health, 
industry and basic science.  Though rich in ex-
amples of placebo-like effects, a full discussion is 
beyond our scope.  Instead, we briefly examine 
two examples, taste and colour, as interesting il-
lustrations of combined biological and cultural 
influences on diet.  
Of the known bitter taste receptor genes, 
TAS2R38 is the most studied.  It is broadly tuned 
to perceive thiourea compounds commonly 
found in crucifers (cabbage family), green tea 
and soya.  Recognized as a genetic trait long 
before TAS2R38 polymorphisms were identi-
fied, individual taste sensitivity to bitter tasting 
phenylthiocarbamide (PTC) and 6-n-propyl-
thiouracil (PROP) distinguished individuals 
as super-tasters, medium tasters or non-tasters 
(Bartoshuk, Duffy, & Miller, 1994).  Subsequent 
studies hypothesized that this variation affects 
individual food preferences, dietary behaviours 
and, through reduced consumption of vegetables, 
physical health.  Although perceptions of bitter 
and sweet taste, the texture of fat and the astrin-
gency of alcohol associate well with PROP/PTC 
tasters status, studies fail to consistently report 
any relationship between TAS2R38 haplotype and 
dietary habits, anthropometric measurements or 
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disease risk (Gorovic et al., 2011; Navarro-Allende, 
Khataan, & El-Sohemy, 2008; Ooi, Lee, Law, & 
Say, 2010; Timpson et al., 2005), suggesting that 
psychological and cultural factors outweigh ge-
netically determined taste perception with regard 
to personal food choices (Gorovic, et al., 2011; 
Navarro-Allende, et al., 2008; Ooi, et al., 2010)..  
Colour
All of the chemical traits discussed to this point 
involve genetic components and direct interac-
tions between food or drug constituents and 
physiological processes or biochemical pathways. 
Moreover, such interactions require consumption 
and, with a few exceptions, represent bottom–
up effects.  In contrast, colour invokes expecta-
tions and elicits responses cued only through vi-
sual stimuli that are independent of the specific 
structure of colour-producing chemicals*.  The 
well-established stimulant effect of red pills and 
the sedative effect of blue pills reflect the mean-
ing ascribed to the respective colours.  The ob-
served culture- and context-dependent varia-
tion in meaning (Moerman, 2011) highlights the 
psychological underpinnings of the response 
as well as the role of macro-context.  When as-
sociated with food, colours take on new mean-
ings that shape consumer perceptions of flavour 
and quality through expectations and learned 
associations derived from previous experience. 
For example, when presented with liquids of 
various colours and asked what flavour they ex-
pected of each, the most popular response from 
British people was cherry for red and raspberry 
for blue while Taiwanese most frequently identi-
fied red as cranberry and blue as mint (Shankar, 
Levitan, & Spence, 2010).  Colour also strongly 
influences flavour perception, green-coloured 
cherry-flavoured drinks are sometimes reported 
as tasting like lime, for instance (DuBose, 1980). 
Independent of sugar content, the addition of red 
colour to drinks increases perceived sweetness 
(Johnson, 1982), but not always (Strugnell, 1997), 
suggesting cultural influences are again involved. 
Similarly, the odour of coloured solutions is per-
ceived as more intense than those of equally-
scented clear solutions (Zellner, 1999).
In the sophisticated world of wine, red not 
only denotes distinct qualities but also beckons 
its own vernacular.  In a study of 54 untrained 
wine-tasters, everyone described an artificially 
red-coloured white wine as a red wine based 
on its aromatic qualities (Morrot, Brochet, & 
Dubourdieu, 2001).  Even wine experts are sus-
ceptible to “placebo” red wine; the aromas of a 
red-coloured white wine were more accurately 
judged when the wine was presented in opaque 
rather than clear glassware (Parr, Heatherbell, & 
White, 2002) and red-illumination of white-wine 
enhances perceived attributes of spiciness and as-
tringency (Ross, Bohlscheid, & Weller, 2008).  
Shape and format
Given that we are free to choose our own meals 
and that what we see affects taste and experience, 
the physical appearance of food heavily influ-
ences consumption.  At the grocery store, we seek 
perfect-looking products.  Beneficially, this serves 
as a safeguard against spoiled or unsanitary foods 
but, counterproductively, can also reflect the use 
of pesticides, waxes or preservatives rather than 
nutritional quality or flavour.  At the table, we of-
ten want what looks good on the plates of other 
people.  Conversely, if deemed unappetizing, cer-
tain foods can eradicate appetite on sight.  
In medicine, different pharmaceuticals share 
several physical qualities; they are clean, evenly 
coloured, free of visual contamination and pack-
aged in a labelled box or container. Also, because 
of the context of use, drugs are associated with 
medicine regardless of their mode of delivery.  The 
psychological impacts of a pill or needle, however, 
differ.  For example, placebo injections are more 
effective than pills for treating migraines (de 
Craen, Tijssen, de Gans, & Kleijnen, 2000).  The 
effects of food format, for instance liquid versus 
solid foods, on appetite and satiety are unclear. 
Despite reports that liquids trigger satiation path-
ways less effectively than solids, leading to the re-
cent admonition of sweetened beverages for their 
putative role in escalating rates of obesity, stud-
ies also report that liquid nutrients are equally or 
more satiating than solids (Almiron-Roig, Chen, 
& Drewnowski, 2003).  This variability is not sur-
prising since hunger, appetite and satiation result 
not simply from the activation of specific chemo-
receptors in the gastrointestinal system but from 
the accumulation and integration of physiologi-
cal, sensory and cognitive factors.  
Food and nutrient format potentially affects 
consumer beliefs and decisions.  Soy protein, for 
example, appears in countless shapes and tex-
tures. In nutritional terms, ‘sugar’ refers to mono- 
and disaccharides of different forms, sources and 
names but refers specifically to sucrose (table 
sugar) on food label ingredient lists.  As a result, 
other forms are regularly added to foods: the 
more obvious brown, confectioner’s, granulated, 
invert, maple, raw and white sugars as well as the 
less transparent processing variants (e.g. corn syr-
up, evaporated cane juice).  Consumers inclined 
to read the list likely consider such ingredients, 
however interpreted, in making food choices.  
 
* Because similarly coloured 
agents in foods and drugs 
are often chemically distinct, 
their biological activities (if 
present) likely work through 
distinct biochemical mecha-
nisms.
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Number and quantity
How does quantity affect food consumption, di-
etary habits and the TFE?  Looking first to medi-
cal research, four placebo pills are more effective 
than two for treating duodenal ulcers (de Craen 
et al., 1999).  The meaning and expectancy asso-
ciated with more pills is higher dose and greater 
response whether presented with real drugs or 
placebos.  Because of difficulties in creating ap-
propriate placebos for food psychology and nu-
trition research, comparable studies are lacking. 
Even if using liquid foods, the water necessary for 
dilution could influence intake as much as any 
nutrient or sensory quality.  Nutritional supple-
ments (which are typically not considered food) 
could provide some transitional insight but stud-
ies focusing on placebo effects in appropriate 
RCTs have not been reported.  The potential for 
placebo-like effects related to the quantity of a nu-
trient are nonetheless plausible.  
Although the immunosupportive effects of 
vitamin C are well substantiated, research has yet 
to conclusively show that, in foods or as supple-
ments, it prevents or reduces the duration or se-
verity of colds*, even at doses more than ten times 
the daily recommended value (Douglas, Hemila, 
Chalker, & Treacy, 2007).  Still, despite the recent 
conclusion that, “routine mega-dose prophylaxis 
is not rationally justified for community use,” 
(Douglas, et al., 2007) a great many people con-
tinue consuming vitamin C in large amounts ex-
pecting relief or protection from cold-like symp-
toms.  The popular ‘more is better’ mentality of 
patients seeking drug therapy may thus apply for 
those seeking nutritional interventions but not 
as well to consumers seeking nourishment more 
broadly.
Analogous to pill number with relevance to 
food consumption, especially overeating, is serv-
ing size.  Numerous studies, both laboratory 
and free-living, unfailingly demonstrate that in-
creased serving size results in increased energy 
intake (Ello-Martin, Ledikwe, & Rolls, 2005; 
Fisher & Kral, 2008).  This means that, regardless 
of what you ate for dinner, you eat more popcorn 
at the movies if you buy a large instead of a small. 
Here, cognitive attention and visual difficulty in 
judging portion size from larger containers are 
but two of the factors at play; the social environ-
ment and associated behavioural norms add an-
other level of complexity.  Increasing the number 
and variety of offered food items (e.g. popcorn, 
candies, nachos) similarly leads to higher energy 
intake (Cohen, 2008).  
Price and labels
Like taste, colour and number, industry- and 
market-designated traits like price, brand name 
and packaging present both sensory and social 
cues that consumers associate with quality, value 
and, in the case of health foods and medicines, 
efficacy.  The additional role of language and 
imagery, from product labels to magazines and 
the internet, in creating such learned, socially 
and culturally-contrived associations cannot 
be underestimated.  The influence of direct-to-
consumer advertising by the pharmaceutical in-
dustry on patient treatment preferences serves 
as case in point (Datti & Carter, 2006; Mintzes et 
al., 2003).  In a classic demonstration of ‘brand’ 
effects in treating headache, patients received an 
unlabelled placebo, a branded placebo, an unla-
belled analgesic or a branded analgesic.  An hour 
after administration, analgesic pills were more 
effective than placebos but, for both treatments, 
branded pills outperformed unlabelled ones 
(Branthwaite & Cooper, 1981).  Similarly, follow-
ing electrical shocks to the wrist (an established 
protocol in pain research) prior to and after tak-
ing the pill, participants given ‘regular-price’ 
placebos reported greater pain relief than par-
ticipants given ‘reduced-price’ placebos (Waber, 
Shiv, Carmon, & Ariely, 2008).  
Interestingly, the study’s motivation for ex-
ploring the therapeutic consequences of a drug’s 
commercial traits stemmed from earlier research 
on the placebo effects of marketing on perfor-
mance (puzzle-solving) following consumption 
of a food, an energy drink.  By manipulating con-
sumer expectations of quality without the use of 
placebos, the authors found that performance was 
affected not only by price but by previous brand 
exposure, self-reported expectancies and the pro-
vision and strength of materials supporting prod-
uct efficacy (Shiv, 2005).  More specifically, dis-
counted price led to poorer performance, likely 
through unconscious processes since the effect 
was lost when attention was brought to popu-
lar price-quality beliefs.  Notably, regular-priced 
drinks did not improve performance relative to 
the control group unless accompanied by strong-
ly supportive statements, which also significantly 
improved self-reported alertness but not moti-
vation, the former a major product claim — to 
“boost alertness” — and the latter lacking any di-
rect association (Shiv, 2005).  
Because consumers perceive lower-priced 
items — foods, drugs or other — as lesser in qual-
ity, they judge them as such (Gerstner, 1985; Roe, 
 
* Vitamin C supplementa-
tion for prophylaxis but not 
treatment may be justified 
in people exposed to severe 
physical activity and to cold 
environments (Douglas et 
al., 2007).
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1989).  Furthermore, a drink labelled with a pre-
ferred brand can taste better and differentially 
activate the brain than the same unlabelled drink 
(Allison, 1964; McClure et al., 2004) and meat 
labelled as 75% lean tastes better than the same 
meat marked as containing 25% fat (Levin, 1988).
Personal experience
Previous experience with the sensory stimuli and 
specific effects of food or medical care lead to 
physiological and psychological responses medi-
ated at both the unconscious and conscious level. 
Considered an underlying mechanism of medical 
placebo effects, classical conditioned (Pavlovian) 
responses are well-documented in the realm of 
diet, most notably conditioned taste aversions 
and, of course, salivating at the sight or smell of 
food (Klosterhalfen et al., 2000).  Response expec-
tancies form another core mechanism of placebo 
effects.  With conscious exposure to any stimulus, 
in this case perceived food traits, personal experi-
ences become integrated into memories, attitudes 
and expectations about that stimulus, influencing 
future experiences (Kirsch, 1999).  While expec-
tancy effects are acknowledged factors in both 
eating and healing, our experience with foods and 
flavours is broader and more deeply rooted than 
our experience with different medical treatments. 
This intimate, ongoing interaction between diet, 
mind and body — past, present and future — forms 
the foundation of personal food preferences and 
aversions ultimately manifesting as choices and 
habits that affect nutrition and health.
Memory is imperfect.  False memories, 
good and bad, can alter people’s attitudes about 
food as well as their future decisions and ac-
tions (Bernstein & Loftus, 2009).  Focusing on 
how memories influence behaviour, most of this 
psychological research has targeted foods like 
hard-boiled eggs, asparagus and dill pickles with-
out concern for implications to personal health. 
One American study, however, demonstrated 
that people convinced they experienced a nega-
tive event involving a  fattening  food as a child 
avoided it in the future (Bernstein, Laney, Morris, 
& Loftus, 2005).  Although memories manipu-
lated through suggestion can potentially improve 
nutrition, the avoidance effect was only observed 
with regard to infrequently encountered high-
fat foods (Bernstein, et al., 2005) suggesting that 
overall dietary habits are harder to break.
Second-hand knowledge
External information also influences beliefs and 
expectations leading to (perceived) consumer 
knowledge and enhanced awareness.  Whether 
true or false, such information may be derived 
from an array of sources including spoken, 
written, and online evidence or accounts, ob-
served experiences of family and friends or any 
common knowledge founded in the macro-
context of use.  This applies equally to food and 
medicine but with some deviation in emphasis. 
Information pertaining to health risks and ben-
efits dominate practitioner and patient choices 
while packaging and second-hand knowledge 
of palatability, seldom a concern when choosing 
medicine, are often central to decisions about new 
foods.  Similarly, patients using opiates probably 
do not care if the poppies were grown under or-
ganic conditions ten or ten thousand miles away 
and diners probably give no additional credence 
to restaurant recommendations from their doc-
tors over friends.
The impacts of micro-context
Filled with staff, furniture, appliances and other 
sensory stimuli symbolic of food and cooking, 
kitchens and dining rooms are inherently asso-
ciated with eating.  Most restaurant owners pay 
meticulous attention to the floor plan, décor, 
lighting and music in order to create an envi-
ronment appropriate for their clientele and the 
dining experience they wish to present.  Though 
not for commercial purposes, many home own-
ers invest in the design and décor of their dining 
rooms for similar reasons of culture, comfort and 
cleanliness. 
The importance of setting in healthcare was 
documented by Florence Nightingale in the 19th 
century, noting that noise, light, ventilation and 
sanitation affected the health of English soldiers 
in her care (Nightingale, 1860).  Today, mounting 
evidence confirms that characteristics of health-
care facility environments influence the health of 
both patients and staff (Rubin, 1998) leading to an 
emergent area of research into healthcare design 
(Ulrich, Berry, Quan, & Parish, 2010; Zborowsky 
& Kreitzer, 2008).  Table 1 lists some relevant 
physical and social elements of micro-context 
that contribute to outcomes. If a hospital room 
with a window or single occupancy benefits pa-
tients more than a windowless or shared room 
(Table 1), how does this translate into eating envi-
ronments and their effects on diet and nutrition? 
Most relevant studies focus on external in-
fluences on food consumption.  As noted above, 
the size of food portions can affect intake, as can 
the mere sight of food and its physical proximity 
(Wansink, 2004).  Watching television or a movie 
increases food consumption.  All of these effects 
involve cognitive processes such as attention 
and self-control, which are further modulated 
by other internal and external inputs. Common 
preference for ‘a table by the window’ suggests a 
Classical conditioning 
Initially described as Pav-
lonian conditioning or rein-
forcement, classical condition-
ing involves the unconscious 
pairing of a response naturally 
triggered by one stimulus to 
another, formerly neutral, 
stimulus.  For example, as a 
result of Pavlov repeatedly 
ringing a bell prior to feeding 
his dog, the dog began to 
salivate at the sound of the 
bell alone. 
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similarly positive effect as a window in healing. 
Lighting also alters perceived tastes and calorie 
consumption (Wansink, 2004) with darkness 
confusing subjective satiety leading to greater 
food intake and inaccurate estimates of consumed 
calories (Scheibehenne, Todd, & Wansink, 2010). 
Alternatively, without vision, attention to other 
senses is heightened and enriches taste experi-
ences, an effect promoted by trendy restaurants 
premised on fine-dining in complete darkness. 
Perhaps an analogue of medicine’s high-tech, cut-
ting-edge interventions associated with powerful 
placebo-like effects (Kaptchuk, Goldman, Stone, 
& Stason, 2000; Moerman, 2011), ‘dark’ restau-
rants may more appropriately owe their success 
to their modernity and the social and cultural es-
teem of the experience.  
Although single-occupancy rooms may im-
prove certain outcomes compared to shared fa-
cilities, this does not imply that social support 
and interaction is negative; the opposite is in fact 
true (Detillion, Craft, Glasper, Prendergast, & 
DeVries, 2004; DeVries, Craft, Glasper, Neigh, & 
Alexander, 2007).  Rather, shared medical facili-
ties may be undesirable for similar reasons as get-
ting the table next to the washrooms.  Whereas 
medicine is mostly private in Western cultures 
but social in others, as presented by Kirmayer 
(2011) in this issue, eating is almost universally a 
social activity with shared relations, experiences 
and cultures as a common point of reference. 
Still, the impact of social environment depends 
on individual preference and the context of eat-
ing.  Eating socially or alone influences nutrition-
al quality and energy consumption perhaps due 
to differing social pressures to arbitrate personal 
behaviour (Wansink, 2004).
The impacts of macro-context 
As the source of culturally-dependent meanings 
ascribed to colour, format, number and price, the 
role of macro-context in the TFE and TDE is over-
arching.  Other examples include the geographi-
cal, economic and cultural contributions to ac-
cessing, experiencing and interpreting foods and 
cuisines.  Agricultural subsidies shape food mar-
kets by manipulating the availability and price of 
selected foods.  Subsidized corn farming in the 
U.S. and the explosion of corn-based products 
in American diets is a clear illustration. Cultural 
norms dictate what types of food are acceptable 
and how they should be presented. Serving fish 
without the head may be more appealing to some 
consumers but also reduces the amount of avail-
able nutrients.  Whereas the production and sale 
of genetically modified foods is well-established 
in North America, it is not tolerated in Europe. 
A highly nutritious and abundant food source, 
insects are considered taboo in some cultures but 
staples or delicacies in others.  Whether we are 
conscious of it or not, macro-context often out-
weighs nutrition in our dietary habits and food 
cultures. 
The typologies of  
food-related placebos and 
placebo effects 
The variety of presented food- and medicine-
related examples reveal that different interactions 
are central to different placebo-like effects.  For 
example, unconsciously learned food aversions 
are typically based in conditioning whereas eat-
ing more from bigger bowls or less when ordering 
from calorie-labelled menus are cognitive effects. 
Both categories, like other possibilities (e.g. ex-
pectancy effects), can be divided and subdivided 
into more specific variants.  Rarely, however, is 
only one mechanism at play.  An alternative ap-
proach is to classify effects according to their 
founding relationships. The influence of price 
and marketing claims on puzzle solving after con-
suming an energy drink similarly implicates mul-
tiple relationships: consumer–food (condition-
ing and expectancies related to prior exposure), 
source–consumer (suggestion and attention re-
lated to externally provided information), as well 
as macro-context effects (mass media depictions 
and common perceptions of energy drinks). 
Feature Effect on patient health Effect on staff health 
Disruptive noise ↑ stress (Hilton, 1985) ↓ sleep (Richardson, Allsop, Coghill, & 
Turnock, 2007); 
↓ preterm infant development (Brown, 2009) 
↑ stress (Choiniere, 2010; Ryherd, Waye, & 
Ljungkvist, 2008);                          
↓ communication (Shapiro & Berland, 1972) 
Controlled noise ↓ pulse amplitude & re-hospitalization of coronary care patients 
(Hagerman et al., 2005) 
↑ speech intelligibility,  
↓ pressure and strain (Blomkvist et al., 2005) 
Lack of window ↑ disorientation; ↑ delusions (Keep, James, & Inman, 1980)  
Sunny rooms & views ↓ length of stay (Beauchemin & Hays, 1996) 
↓ mortality after myocardial infarction (Beauchemin & Hays, 1998) 
↓ use of analgesics (Ulrich, 1984) 
↑ job satisfactions (Mroczek, Mikitarian, Vieira, & 
Rotarius, 2005) 
↑ well-being (Leather, 1998) 
Private vs. shared rooms ↓ infection (Shirani et al., 1986) ↓ stress  (Chaudhury, Mahmood, & Valente, 2006) 
 Table 1. Examples of how micro-context traits impact the health of patients and healthcare staff.
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Whereas analogies of placebos in food and 
nutrition expose the same core mechanisms of 
medical placebo effects, the exercise offers sev-
eral novel variations on conventional types and 
relational structures.  With clinically and self-
prescribed dietary interventions or health foods, 
practitioners prescribe and patients purchase 
what they believe and expect will help.  As such, 
those without proven benefit in RCTs can be con-
strued as superplacebos (Ernst, 2001).  
Food labels present a unique permutation of 
the placebo paradigm where, despite receiving 
accurate information, consumers often under- or 
overestimate their nutrient intake due to a lim-
ited understanding of food labels and nutritional 
recommendations.  Artificial sweeteners and fat 
substitutes present another interesting variation. 
Sugar- and fat-free foods are designed to simulate 
calorie-rich foods in every way except their ‘ac-
tive’ components, which in this case are associated 
with negative health outcomes (Hung, et al., 2003). 
Here, people knowingly consume these placebo 
foods expecting to reduce their risk of developing 
conditions such as diabetes, obesity and cardio-
vascular disease while enjoying the pleasures of 
indulgence. However, lacking the specific stimuli 
to activate the brain’s reward circuitry, low-calorie 
alternatives often fail to provide the same sensory 
experience as the real thing.  Perceived lactose in-
tolerance offers yet another variation where con-
sumers who falsely overestimate their inability to 
tolerate dairy not only react to lactose challenge 
but avoid dairy of all sorts, regardless of lactose 
content, with obvious dietary and nutritional im-
plications (Casellas et al., 2010). 
Placebo drugs are more effective in some 
circumstances than others (Benedetti, 2009). 
The evidence presented here similarly demon-
strates that certain aspects of diet and nutrition 
are more or less responsive to placebo-like in-
teractions.  Placebo effects are insignificant with 
regards to nutrient deficiencies but often robust 
in trials on diet-related problems such as IBS and 
lactose intolerance (Casellas et al., 2010; Enck & 
Klosterhalfen, 2005; Kaptchuk, et al., 2010) as well 
as food-based intervention studies for the com-
mon cold (Carr, Einstein, Lai, Martin, & Starmer, 
1981) and postmenopausal hot flushes (Nahas et 
al., 2007).  Moreover, food-related placebo effects 
may be subjective or objective, as exemplified by 
flavour perception and caloric intake, and present 
short- or long-term consequences, as exemplified 
by enhanced cognitive performance and condi-
tioned taste aversions, respectively.
In the medical literature, debate abounds re-
garding the definition, interpretation and use of 
the terms placebo and placebo effect.  Because 
direct analogies of narrowly-defined placebos are 
scarce in diet, we adopt more inclusive definitions 
that serve well as an umbrella term since many 
such effects involve pleasing and desirable (pla-
cebo) or displeasing and undesirable (nocebo) 
responses to real or perceived stimuli.  
 Toward a common neurobiology? 
Neurologically speaking, relieving (or suppress-
ing) discomfort and getting rewarded share 
much in common.  When someone wants to sup-
press hunger-related discomfort, he/she is actu-
ally seeking the reward of food, which in itself 
is a means of relieving hunger.  Identified as the 
brain’s motivation and reward centre, the meso-
limbic dopaminergic system drives the seeking 
behaviours and rewards associated with eating, 
sex, gambling and euphoric or addictive drugs. 
Seeking relief from sickness is probably more like 
hunger and thirst than sex or gambling in that 
failure to act can be harmful to health and sur-
vival (Benedetti, 2010).  Thanks to evidence de-
rived almost exclusively from placebo research, 
we also know that expectations of treatment and 
improvement can activate the mesolimbic dopa-
mine system of patients afflicted with pain, de-
pression and Parkinson’s disease (Benedetti, 2010; 
de la Fuente-Fernandez, Lidstone, & Stoessl, 
2006; Zubieta & Stohler, 2009).  
With expectancies appearing prominently in 
many diet-related placebo effects, dopamine like-
ly plays a pivotal role here as well.  However, given 
the integrated inputs mediating eating behaviour, 
other neurotransmitters and systems (e.g. endo-
crine, digestive, olfactory, etc.) are undoubtedly 
involved.  Implicated in both placebo analgesia 
(Benedetti, 2006) and eating patterns (Davis et 
al., 2011), the opiate system is a promising candi-
date worthy of investigation.
Caveats and limitations
Beyond the previously addressed practical and 
conceptual limitations of nutritionally inert 
foods, our adapted model suffers from certain 
pre-existing limitations of the TDE approach as 
well as additional ambiguities and complications, 
particularly with regard to time and complexity.  
Temporal constraints
Many human traits and corresponding in-
teractions with food traits change with time. 
Accordingly, the TFE includes temporal consid-
erations: consumer age, short-term and long-
term effects of a single ‘dose’ and acute versus 
chronic consumption. Pharmaceutical (and 
Superplacebos 
Coined in reference to 
CAM, the term refers to 
interventions without spe-
cific benefit when examined 
objectively yet believed to be 
effective by both the patient 
and practitioner.  Due to 
these shared beliefs and 
expectations, superplacebos 
can generate superplacebo 
effects (Ernst, 2001). 
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placebo) research focuses primarily on the short-
term effects of drugs (meaning or context) on a 
particular set of outcomes while long-term effects 
often remain unclear.  The vast majority of the 
provided examples from food and diet similarly 
involve only acute effects.  Although the long-
term health impacts of individual nutrients can 
be ascertained by epidemiological approaches, at 
least correlatively, those of any specific food are 
much more difficult to assess at either the indi-
vidual or population level.
Mentioned only briefly here, the influence of 
age on TFE deserves greater attention.  In medi-
cal, nutrition and placebo research, paediatric, 
adult and geriatric individuals require separate 
consideration for reasons of biological, cognitive 
and socio-cultural development.  Given that di-
etary preferences and habits form predominantly 
in early years, that marketing of food directly 
targets children, and that youth are, on average, 
more susceptible to suggestion, authority and 
placebo effects than adults (Kemeny et al., 2007; 
Lewis, Winner, & Wasiewski, 2005; Rheims, 
Cucherat, Arzimanoglou, & Ryvlin, 2008), the 
model warrants revisiting with a focus on child-
hood.  Mindful of these limitations, we feel that 
the proposed model is sufficiently flexible for ap-
plication to both short- and long-term effects of 
food and diet across the lifespan.
Quantity and complexity of inter-
actions
In medicine, a patient normally consults with one 
or two practitioners who diagnose and treat then 
monitor response until treatment is discontin-
ued.  Even with multiple prescriptions, the TDE 
of each remains somewhat confined by the dura-
tion of exposure and symptoms and the limited 
treatment traits interacting within the clinical 
encounter.  If eating multiple times a day in mul-
tiple settings, dozens if not hundreds of sources 
contribute different foods containing thousands 
of chemicals to our daily diet.  Duration of ex-
posure is rarely based on symptomatology but 
instead on availability, affordability, previous ex-
perience and culture, which collectively influence 
how frequently and copiously we consume differ-
ent foods. As such, the number and complexity of 
interactions between stakeholder traits clouds the 
TFE of a single food, a particular meal or, most 
profoundly, an entire diet.
The ambiguity of the TFE’s ‘source’ compo-
nent can add more variables and the limitations 
of self-reported, recalled dietary and lifestyle 
habits constrain the validity of interpretations 
and conclusions.  Nonetheless, compared to 1970 
when Claridge introduced the TDE, progress in 
placebo research and our understanding of non-
pharmacological factors in medicine, though 
still bourgeoning, has increased profoundly 
(Benedetti, 2009, 2010; Moerman, 2002).  With 
evolving experimental paradigms, we can simi-
larly dissect the TFE by judiciously manipulating 
selected variables while controlling for as many 
others as possible.
Closing Remarks
A wealth of research relevant to the TFE is scat-
tered among different disciplines and sub-disci-
plines, each with their own interests and objec-
tives.  With the overarching emphasis of health 
on most research agendas worldwide, increasing 
prevalence and economic burden of diet-related 
diseases and greater acknowledgement of psy-
chological, cultural and environmental factors in 
diet and health, converging evidence continues to 
emerge.  Bringing some of this research togeth-
er for the first time, the current paper identifies 
some of the known and unknown factors at play, 
giving body to the TFE framework. The publica-
tion of industry-generated, proprietary research 
regarding the effects of food appearance, flavour 
and marketing on consumer perceptions, prefer-
ences and consumption habits would provide a 
big step forward.  Though unlikely, we can still 
hope.
Our relationships with food are complex, ex-
tending beyond nutrition, physiology, psycholo-
gy or any other single perspective.  Only through 
an interdisciplinary approach can we study and 
eventually understand the multi-layered interac-
tions shaping the impacts of food on our personal 
and collective health.  By extending the concept 
of placebos to diet and food culture, we not only 
gain new insights into mechanisms governing 
food-related behaviours and responses but also 
into clinical practice and research, diverse aca-
demic disciplines as well as industry and public 
health policy.  Importantly, we can also identify 
new models and innovative avenues for studying 
placebo-related phenomena without some of the 
constraints imposed by medical research.
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